Research and Development of formulations - CRO

Led team of scientists working on formulation development of solid orals/semisolids/liquids and soft gel capsules

Development and scale-up of conventional drug delivery systems like immediate release and modified release tablets, capsules for NCEs and generics, powder for suspension, liquid filled hard gelatin capsules etc.

Novel drug delivery systems like micro-emulsions, nanosuspensions, liposomes, niosomes, solid-lipid nanoparticles and floating beads etc.

Biopharmaceutical and bioequivalence aspects of dosage forms as well as sample size determination and data review of bioequivalence studies in humans.

Development of preclinical efficacy and toxicology formulations.

CAPEX plan, proposals for projects, managing Clients across US, UK, Europe and Worldwide


Contact with More details
Shruti P. Bodele
Sales Manager
9309893460
Diponed Research International Pvt Ltd, Bangalore
Shruti@diponed.com

India is increasingly becoming a preferred destination for the global pharmaceutical supply chain, according to a recent report by Macquarie. The country’s strong manufacturing capabilities, cost efficiency, and regulatory reforms are driving its growth in the sector.

The report highlights that India’s pharmaceutical industry, already valued at over $50 billion, is poised for further expansion as global companies seek to reduce dependence on China. With a well-established ecosystem of raw material suppliers, skilled workforce, and world-class production facilities, India offers a competitive edge in active pharmaceutical ingredients (APIs) and generic medicines.

Government initiatives such as the Production-Linked Incentive (PLI) scheme and policy support for domestic API production have further strengthened India’s position. Additionally, rising investments in research and development (R&D) and the adoption of advanced technologies, including AI-driven drug discovery and digital healthcare solutions, are making India an attractive hub for global pharma giants.

With increasing partnerships, export growth, and a favorable policy landscape, India is set to play a crucial role in ensuring a resilient and diversified global pharmaceutical supply chain. As multinational firms continue to shift their sourcing strategies, India stands out as a key beneficiary of this transformation.

#PharmaceuticalIndustry #IndiaPharma #GlobalSupplyChain #APIs #DrugManufacturing #HealthcareInnovation #MedTech #PharmaGrowth #MakeInIndia #PLI #HealthcareStartups #DigitalHealth #Biopharma #R&D #AIinHealthcare #PharmaExports #SupplyChainResilience #HealthcareTech #Dseidehealthcarenetwork

Source: Financial Express

Manipal - Government of Karnataka Bioincubator, a Technology Business Incubator (TBI) was established with the support of Manipal Academy of Higher Education (MAHE), K Tech-Government of Karnataka and BIRAC - Department of Biotechnology, Government of India.

Manipal-GoK Bioincubator-BioNEST and its Student Entrepreneurship Cell in association with Manipal College of Pharmaceutical Sciences (MCOPS), MAHE, Manipal is organizing an online Manipal BioPharma Hackathon 2025, scheduled on February 25th, 2025.

This Hackathon is conducted with the vision to promote student innovations, start-up creation and encourage critical thinking skills essential to address the most pressing issues in the BioPharma domain.

The hackathon comprises two important segments:

Euphoria 10.0 on February 03rd, 2025 at 9:15 am: A segment featuring virtual engaging talks focused on brainstorming participants about pertinent topics in the Pharma/BioPharma field, emphasizing innovations and technology.

Grand Finale on February 25th, 2025: Participating teams will virtually pitch their ideas to a closed group of jury members.

The entire event will be conducted online via the MS Teams platform. Participation is open to all students and researchers affiliated with academic or research institutions (UG/PG/Doctoral studies). Individuals who do not have teams are encouraged to create multidisciplinary teams by registering individually and connecting with other solo registrants in the event (Teammate Lookout BioPharma Hackathon).

Exciting rewards await participants, including the opportunity to win prize money of up to INR 1 lakh, a pre-incubation period lasting 6 months, and potential seed funding of up to INR 25 lakhs. Additionally, participants will have access to valuable technical sessions and mentoring. We extend a warm invitation to the students of your Institute/University to join us in the nationwide virtual Manipal BioPharma Hackathon 2025.

We have also provided the event brochure and guidelines, along with the Rules and Regulations, which can be distributed among students and displayed on your college notice boards. We kindly request your assistance in making these arrangements, and it would be highly appreciated if at least one team from your institution could participate in the event. If you require any further information, please feel free to contact us.

Best Regards,